Trials / Conditions / Acute ST Segment Elevation Myocardial Infarction

Acute ST Segment Elevation Myocardial Infarction

23 registered clinical trials studyying Acute ST Segment Elevation Myocardial Infarction.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Predictive Value of Combining AccuIMR and AccuFFR in Patients With STEMI NCT06435728	Peking University Third Hospital	—
Completed	Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility NCT05949515	Cardiovascular Research Foundation, New York	—
Unknown	A Cohort Study of Correlation Between Mast Cells and Prognosis in Patients With Acute Myocardial Infarction NCT05802667	Peking University Third Hospital	—
Unknown	DCB Under the Guidance of OCT in STEMI NCT05680051	Henan Institute of Cardiovascular Epidemiology	N/A
Terminated	Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Int NCT04571580	Ge Junbo	Phase 3
Completed	Predictive Value of CHA2DS2VASC Score for Contrast-induced Nephropathy After Primary Percutaneous Coronary Int NCT04730778	Cairo University	—
Unknown	Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients NCT04861389	Shenzhen People's Hospital	N/A
Completed	Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 NCT04463251	R-Pharm Overseas, Inc.	Phase 2
Unknown	Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis at Different Time NCT03137212	Second Hospital of Jilin University	N/A
Unknown	FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction NCT02943954	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis NCT02298088	Hospital do Coracao	Phase 3
Unknown	Effects of Glucagon Like Peptide-1 on No-reflow NCT02507128	Chen Wei Ren, MD	N/A
Completed	Platelet Function in Resuscitated Patients NCT02914795	Medical University of Graz	—
Withdrawn	The RESTORE-SIRIO Randomized Controlled Trial NCT02405130	Heinrich-Heine University, Duesseldorf	N/A
Unknown	Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct NCT02067091	Haukeland University Hospital	Phase 3
Completed	EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarct NCT01930682	RenJi Hospital	Phase 4
Completed	ABSORB STEMI: the TROFI II Study NCT01986803	ECRI bv	N/A
Withdrawn	Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis NCT02048085	Medical Center of South Arkansas	Phase 4
Completed	Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study NCT02828683	Terumo Europe N.V.	N/A
Completed	An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarctio NCT01787110	Karolinska Institutet	Phase 3
Active Not Recruiting	Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention NCT01878344	Suleyman Demirel University	Phase 3
Unknown	Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance NCT00697021	Assaf-Harofeh Medical Center	Phase 3
Completed	Prognostic Implication of Angiography-Derived IMR in STEMI Patients NCT04628377	Samsung Medical Center	—